May 8, 2025
Adobe

NIH grant terminations under Trump have totaled at least $1.8 billion, analysis finds

National Institute on Minority Health and Health Disparities had largest percentage cut; authors hope people see the ‘scope of terminations'

By Anil Oza


STAT+ | RFK Jr. wants Americans’ health records to study autism. It’s not that easy to get them

New $50 million HHS data platform aims to combine health records and CMS claims. Past efforts were stalled by issues of data privacy, consent, usage.

By Katie Palmer


RSV sent fewer babies to the hospital last winter, after new treatment and vaccine arrived

This was the first winter in which the Abrysvo vaccine and Beyfortus RSV antibody were available to protect babies from the virus.

By Helen Branswell



Alex Hogan/STAT

Inside the world of internet peptides

Social media influencers hype risky peptides like BPC-157 and melanotan. Experts warn of dangers as unregulated compounds surge in wellness circles.

By Alex Hogan


STAT+ | Democrats urge Republicans to target Medicare Advantage ‘upcoding’ instead of cutting Medicaid

Republicans are considering deep cuts to Medicaid to pay for tax cuts. Democrats say they should go after Medicare Advantage overpayments instead.

By Bob Herman


Bill Gates to accelerate spending at his foundation — then wind it down

Gates Foundation to donate $200 billion over 20 years, then close. Billionaire says it's "faster than I had originally planned," cites urgent global needs.

By Andrew Joseph and Helen Branswell


A firebrand takes oversight of vaccines, gene therapies

STAT's Matthew Herper joins the podcast to examine Prasad's appointment and the band of outsiders now in charge of U.S. health agencies.

By Allison DeAngelis and Adam Feuerstein


STAT+ | More Medicare plans cover Humira biosimilars, but do little to encourage patient use

A report from the inspector general of HHS examines the latest trends since several biosimilar versions of Humira were launched in the U.S. in 2023.

By Ed Silverman


STAT+ | Insitro, an AI biotech founded by Daphne Koller, lays off staff

Insitro, which has branded itself as a grownup among AI biotechs, lays off staff before launching any clinical trials of new drugs.

By Jason Mast


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.